Reducing cesarean sections using the Hamilton maneuver
Latent Phase Membrane Stripping for Caesarean Section Reduction. Single Blind Clinical Trial
NA · Universidad Nacional Autonoma de Honduras · NCT06809985
This study is testing if using the Hamilton maneuver can help first-time pregnant women have vaginal deliveries instead of cesarean sections.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | Female |
| Sponsor | Universidad Nacional Autonoma de Honduras (other) |
| Locations | 1 site (Tegucigalpa, Francisco Morazán) |
| Trial ID | NCT06809985 on ClinicalTrials.gov |
What this trial studies
This study aims to reduce the rate of cesarean deliveries by implementing the Hamilton maneuver to expedite the latent phase of labor in nulliparous women with singleton pregnancies. The research is conducted at Hospital Escuela, where high cesarean rates have raised concerns about maternal morbidity and mortality. By focusing on non-pharmacological interventions, the study seeks to improve delivery outcomes and decrease the need for surgical interventions. The eligibility criteria include women at 37 weeks or more of pregnancy with specific conditions that favor vaginal delivery.
Who should consider this trial
Good fit: Ideal candidates for this study are nulliparous women with singleton pregnancies at 37 weeks or more, presenting with a Bishop's score greater than 7.
Not a fit: Patients who have had previous uterine surgery or any maternal conditions that prevent vaginal delivery will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly lower the rates of cesarean sections, thereby reducing maternal complications and improving overall maternal health.
How similar studies have performed: While the Hamilton maneuver has been used in other contexts, this specific application to reduce cesarean sections is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Submission of a signed and dated informed consent form. * Declared willingness to comply with all study procedures and availability for the duration of the study. * nulliparous * woman with singleton pregnancy at 37 weeks or more * integral membranes * cephalic presentation * Bishop's score greater than 7 * No contraindication for vaginal delivery Exclusion Criteria: * Previous uterine surgery * Maternal condition preventing vaginal delivery * Fetal anomaly * Premature rupture of membranes * Multiple pregnancy * Fetal orbit * Myomas * Maternal comorbidities such as chronic arterial hypertension, type 1, 2 and gestational diabetes, hypothyroidism, among others. * Anemia
Where this trial is running
Tegucigalpa, Francisco Morazán
- Hospital Escuela — Tegucigalpa, Francisco Morazán, Honduras (RECRUITING)
Study contacts
- Study coordinator: Ricardo A. Gutierrez Ramirez, MD, MSc
- Email: ricardo.gutierrez@unah.edu.hn
- Phone: 50497546940
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cesarean Delivery, Cervical Ripening, Latent Phase Labour, Cervical ripening, latent phase labour, hamilton maneuver